The key to moving a new technology out of the labs and into production is being able to demonstrate the value that it delivers. That’s the goal for a new collaboration between the University of Rochester and flexible sensor maker MC10. The company’s Biostamp technology includes printed electronic sensors that connect wirelessly to devices running companion software, which then sends the data to the cloud for storage, analysis, and reporting. This end-to-end system can be used for many applications, including predictive health analytics that can identify when a person is likely to come down with a specific disease.
Rochester researchers will work with MC10 to test the technology in a variety of clinical settings. For example, one group will conduct trials related to neurodegenerative disease. The university has expertise in applying Big Data analytics to healthcare issues. The Biostamp technology will be able to provide frequent measurements of relevant patient biometrics, creating a large collection of information that can be studied to reveal useful signals.
This sort of research can lead to improved preventative care, earlier diagnosis, more effective treatments, and better patient outcomes. The end result will help individuals and save costs for everyone.